Your browser doesn't support javascript.
loading
Both New-Onset and Pre-Existing Hypertension Indicate Favorable Clinical Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor Therapy.
Moriyama, Shohei; Hieda, Michinari; Kisanuki, Megumi; Kawano, Shotaro; Yokoyama, Taku; Fukata, Mitsuhiro; Kusaba, Hitoshi; Maruyama, Toru; Baba, Eishi; Akashi, Koichi; Fukuda, Haruhisa.
Afiliação
  • Moriyama S; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Hieda M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Kisanuki M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Kawano S; Division of Immunology and Rheumatology, Hamanomachi Hospital.
  • Yokoyama T; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Fukata M; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Kusaba H; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Maruyama T; Division of Oncology, Hamanomachi Hospital.
  • Baba E; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital.
  • Akashi K; Division of Cardiology, Haradoi Hospital.
  • Fukuda H; Department of Oncology and Social Medicine, Kyushu University.
Circ J ; 2022 Dec 06.
Article em En | MEDLINE | ID: mdl-36476830
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article